ARCHIVES

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

This article is from The Cancer Letter archive.

Vol. 31 No. 34 | September 23, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Considers Making Prevention Trial From NSABP; Other Groups Approached

May 13, 1994

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

Panel May Take On OMB In Battle to Restore NCI Construction Funds; Two Will Be Funded In FY ‘83

November 12, 1982

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

January 5, 1979